Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026)
Hims & Hers Health (HIMS) posted Amortization of Deferred Charges of $5.0 million for Q1 2026, up 225.91% sequentially from -$4.0 million in Q4 2025.
Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Amortization of Deferred Charges for 7 years, with the latest figure at $5.0 million in Q1 2026.
- Quarterly Amortization of Deferred Charges changed N/A year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (up 495.56% YoY) and the FY2025 annual result came in at $4.5 million, changed N/A from the prior year.
- Amortization of Deferred Charges improved to $5.0 million in Q1 2026 per HIMS's latest filing, from -$4.0 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $5.0 million in Q1 2026 and troughed at -$4.0 million in Q4 2025.
- A 5-year average of $1.1 million and a median of $600000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges changed 0.0% in 2022, then soared 512.5% in 2025.
- Over 5 years, Amortization of Deferred Charges stood at $500000.0 in 2022, then jumped by 40.0% to $700000.0 in 2023, then increased by 14.29% to $800000.0 in 2024, then tumbled by 596.38% to -$4.0 million in 2025, then soared by 225.91% to $5.0 million in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $5.0 million, -$4.0 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.60 Mn |
| Jun 30, 2026 | 5.60 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | -3.97 Mn |
| Dec 31, 2025 | -3.97 Mn |
| Sep 30, 2025 | 4.90 Mn |
| Sep 30, 2025 | 4.90 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Sep 30, 2023 | 600,000.00 |